SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-062410
Filing Date
2019-03-04
Accepted
2019-03-04 16:01:32
Documents
2
Period of Report
2019-02-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d717478d8k.htm 8-K 21608
2 EXHIBIT 99.1 d717478dex991.htm EX-99.1 192865
  Complete submission text file 0001193125-19-062410.txt   215602
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33415 | Film No.: 19653669
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences